Status:
COMPLETED
The Effect of Lamina-G on Gastrointestinal Symptom After Gastric Biopsy
Lead Sponsor:
Kyungpook National University Hospital
Conditions:
Gastrointestinal Symptom
Eligibility:
All Genders
18-80 years
Phase:
PHASE4
Brief Summary
Sometimes, subjects complain about gastrointestinal symptoms after esophagogastroduodenoscopy and biopsy. The aim of this study is to investigate the effect of sodium alginate (Lamina-G®) on biopsy-re...
Detailed Description
This study is an open labeled, single-center randomized controlled trials. Patients who underwent upper enoscopy with biopsy were randomly assigned to medication and control group. In the medication g...
Eligibility Criteria
Inclusion
- Age from 18 to 80 years Persons who assigned on the written consent for the clinical trial. Persons who underwent upper endoscopy and gastric biopsy
Exclusion
- Gastrectomy Severe cardiovascular, pulmonary, or endocrine disease Renal or hepatic dysfunction Hematologic disease Gastric cancer Active peptic ulcer User of proton pump inhibitor, H2 blocker, mucoprotectant Immediate significant bleeding after biopsy Pregnant women Allergy history for sodium alginate
Key Trial Info
Start Date :
March 27 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 10 2019
Estimated Enrollment :
210 Patients enrolled
Trial Details
Trial ID
NCT04134364
Start Date
March 27 2017
End Date
September 10 2019
Last Update
April 24 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kyungpook National University Hospital
Daegu, South Korea, 41404